The Virginia Commonwealth University (VCU) Massey Cancer Center (MCC) organizational structure includes a number of internal and external advisory committees to provide input into strategic planning for development and implementation of the scientific goals of the center. The external scientific advisory group is the Scientific External Advisory Board (EAB), which is composed of scientific experts and leaders from other major cancer centers. In addition to the standing external advisory membership, ad hoc advisors are added to the roster periodically to assess and advise regarding specific programs, shared resources, or inter-programmatic activities. Internal planning and evaluation is a continuous process at MCC that occurs through meetings of the Associate Directors (1st Tuesday of the month), and combined Associate Directors and Program Leaders meetings (3rd Tuesday of the month), and the Senior Advisory Committee (SAC) meetings (2nd Tuesday of the month). It is a policy of MCC that each program has an annual strategic planning retreat. These retreats are supported by MCC funding and provide a forum for more extended scientific interchange as well as membership input into plans for increasing the scientific and translational opportunities of the program through future faculty recruitment, shared resource development, and other mechanisms for increased scientific productivity and collaboration. MCC-wide planning retreats are held in conjunction with the annual all-center scientific retreats as a forum for all members to participate in MCC planning.

Public Health Relevance

Continuing self-evaluation and reappraisal is needed to ensure that MCC is best fulfilling its public health mission. The Program Planning and Evaluation component of the CCSG provides the MCC Director with both internal and external reviews and recommendations against which strategic decisions can be made. The component also supports the individual programs in their own annual, strategic planning.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Virginia Commonwealth University
United States
Zip Code
Ginder, Gordon D (2015) Epigenetic regulation of fetal globin gene expression in adult erythroid cells. Transl Res 165:115-25
Chen, Shuang; Zhang, Yu; Zhou, Liang et al. (2014) A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis. Blood 124:2687-97
Youniss, Fatma M; Sundaresan, Gobalakrishnan; Graham, Laura J et al. (2014) Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling. PLoS One 9:e109162
Teves, Maria E; Sears, Patrick R; Li, Wei et al. (2014) Sperm-associated antigen 6 (SPAG6) deficiency and defects in ciliogenesis and cilia function: polarity, density, and beat. PLoS One 9:e107271
Bie, Jinghua; Wang, Jing; Yuan, Quan et al. (2014) Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice. J Lipid Res 55:729-38
Teramachi, Jumpei; Zhou, Hua; Subler, Mark A et al. (2014) Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone. J Bone Miner Res 29:1456-65
Nakagawa, Akito; Lui, Francine E; Wassaf, Dina et al. (2014) Identification of a small molecule that increases hemoglobin oxygen affinity and reduces SS erythrocyte sickling. ACS Chem Biol 9:2318-25
Sarkar, S; Azab, B; Quinn, B A et al. (2014) Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer terminator virus. Curr Mol Med 14:125-40
Dhall, Sandeep; Do, Danh; Garcia, Monika et al. (2014) A novel model of chronic wounds: importance of redox imbalance and biofilm-forming bacteria for establishment of chronicity. PLoS One 9:e109848
Rahmani, Mohamed; Aust, Mandy Mayo; Benson, Elisa C et al. (2014) PI3K/mTOR inhibition markedly potentiates HDAC inhibitor activity in NHL cells through BIM- and MCL-1-dependent mechanisms in vitro and in vivo. Clin Cancer Res 20:4849-60

Showing the most recent 10 out of 215 publications